Description

TREVIAMET XR 50/500mg Tablet
Overview: This extended-release tablet combines Sitagliptin (a DPP-4 inhibitor) and Metformin to help manage type 2 diabetes. Sitagliptin increases insulin secretion, while Metformin improves glucose uptake and reduces production in the liver.
Uses and Benefits:
Type 2 Diabetes Control: Improves blood sugar levels in adults with type 2 diabetes.
Enhanced Insulin Response: Sitagliptin regulates insulin secretion.
Blood Glucose Regulation: Metformin enhances cellular response to insulin.
Dosage and Administration:
Typically one tablet daily with the evening meal.
Side Effects:
Nausea
Diarrhea
Headache
Upper respiratory infection
Precautions:
Inform your doctor about any kidney or liver conditions.
Regular blood sugar monitoring is advised.
Follow the prescribed dietary plan and exercise regimen.